Evidence map›Paper›PMID 37927213›Full record

ArticleCancer biology & therapy2023

PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.

William S Streitfeld, Annamarie C Dalton, Breege V Howley, Philip H Howe

Open access · goldAbstract read
In one paragraph

Article in Cancer biology & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

William S StreitfeldDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-2791-522X
Annamarie C DaltonDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0009-0008-0798-415X
Breege V HowleyDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0001-9790-8880
Philip H HoweDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0002-1358-1313
Medical University of South Carolina · US

Funding

TGF-regulated EMTR01CA154663 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Philip H Howe · 2011 to 2026
$5.1M
Characterization of ILEI/LIFR Axis-induced Intracellular SignalingF31CA257145 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI STREITFELD, WILLIAM SCOTT · 2021 to 2023
$135k
NCI NIH HHS F31 CA257145NCI NIH HHS R01 CA154663
6 · The paper itself

Abstract

The poly(rC) binding protein 1 gene (PCBP1) encodes the heterogeneous nuclear ribonucleoprotein E1 (hnRNPE1), a nucleic acid-binding protein that plays a tumor-suppressive role in the mammary epithelium by regulating phenotypic plasticity and cell fate. Following the loss of PCBP1 function, the FAM3C gene (encoding the Interleukin-like EMT inducer, or "ILEI" protein) and the leukemia inhibitory factor receptor (LIFR) gene are upregulated. Interaction between FAM3C and LIFR in the extracellular space induces phosphorylation of signal transducer and activator of transcription 3 (pSTAT3). Overexpression and/or hyperactivity of STAT3 has been detected in 40% of breast cancer cases and is associated with a poor prognosis. Herein, we characterize feed-forward regulation of LIFR expression in response to FAM3C/LIFR/STAT3 signaling in mammary epithelial cells. We show that PCBP1 upregulates LIFR transcription through activity at the LIFR promoter, and that FAM3C participates in transcriptional regulation of LIFR. Additionally, our bioinformatic analysis reveals a signature of transcriptional regulation associated with FAM3C/LIFR interaction and identifies the TWIST1 transcription factor as a downstream effector that participates in the maintenance of LIFR expression. Finally, we characterize the effect of LIFR expression in cell-based experiments that demonstrate the promotion of invasion, migration, and self-renewal of breast cancer stem cells (BCSCs), consistent with previous studies linking LIFR expression to tumor initiation and metastasis in mammary epithelial cells.

Indexed as

Breast NeoplasmsDNA-Binding ProteinsRNA-Binding ProteinsCell Line, TumorCell Self RenewalCytokinesEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansLeukemia Inhibitory Factor Receptor alpha SubunitNeoplasm InvasivenessNeoplasm ProteinsReceptors, OSM-LIFSignal TransductionTranscription FactorsCytokinesDNA-Binding ProteinsFAM3C protein, humanLeukemia Inhibitory Factor Receptor alpha SubunitLIFR protein, humanNeoplasm ProteinsPCBP1 protein, humanReceptors, OSM-LIFRNA-Binding ProteinsTranscription FactorsBreast cancerepithelial-mesenchymal transition (EMT)gene regulationinvasionmigrationmolecular cell biologyreceptor regulationsignal transductionSTAT3stem cells

Identifiers

PMID37927213
PMCPMC10629429
OpenAlexW4388415186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.